AGT and triple-A syndrome: Recently, using a pharmacological inhibitor and calpain-1 deficient mice, we demonstrated that calpain inhibition significantly attenuated inflammatory processes present in aortic vascular diseases such as angiotensin II (AngII)-induced abdominal aortic aneurysms (AAA) and atherosclerosis in mice18,19.